These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29493822)

  • 1. Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.
    Lu J; Chen XM; Huang HR; Zhao FP; Wang F; Liu X; Li XP
    Head Neck; 2018 Jun; 40(6):1245-1253. PubMed ID: 29493822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1 high expression predicts lower local disease control in stage IV M0 nasopharyngeal carcinoma.
    Jiang F; Yu W; Zeng F; Cheng G; Xu J; Yang S; Shui Y; Wu D; Yu XF; Wei Q
    BMC Cancer; 2019 May; 19(1):503. PubMed ID: 31138162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated IL18 levels in Nasopharyngeal carcinoma induced PD-1 expression on NK cells in TILS leading to poor prognosis.
    Liou AK; Soon G; Tan L; Peng Y; Cher BM; Goh BC; Wang S; Lim CM
    Oral Oncol; 2020 May; 104():104616. PubMed ID: 32151994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
    Larbcharoensub N; Mahaprom K; Jiarpinitnun C; Trachu N; Tubthong N; Pattaranutaporn P; Sirachainan E; Ngamphaiboon N
    Am J Clin Oncol; 2018 Dec; 41(12):1204-1210. PubMed ID: 29672367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma.
    Zhang J; Fang W; Qin T; Yang Y; Hong S; Liang W; Ma Y; Zhao H; Huang Y; Xue C; Huang P; Hu Z; Zhao Y; Zhang L
    Med Oncol; 2015 Mar; 32(3):86. PubMed ID: 25702326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment.
    Chen TC; Chen CH; Wang CP; Lin PH; Yang TL; Lou PJ; Ko JY; Wu CT; Chang YL
    Sci Rep; 2017 Sep; 7(1):10349. PubMed ID: 28871094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma.
    Cao Y; Chan KI; Xiao G; Chen Y; Qiu X; Hao H; Mak SC; Lin T
    BMC Cancer; 2019 Oct; 19(1):1022. PubMed ID: 31664962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of tumor-infiltrating lymphocytes and macrophages in nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Liu W; Chen G; Zhang C; Liao X; Xie J; Liang T; Liao W; Song L; Zhang X
    Eur Arch Otorhinolaryngol; 2022 Jan; 279(1):25-35. PubMed ID: 34027599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer.
    Zhou F; Shayan G; Sun S; Huang X; Chen X; Wang K; Qu Y; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Shi X; Liu Y; Liang B; Li YX; Wang J; Yi J
    Front Immunol; 2022; 13():1015283. PubMed ID: 36439177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of tumor infiltrating lymphocytes in EBV positive and EBV negative nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg JA; Braunius WW; Zuur CI; Koljenović S; Willems SM
    Oral Oncol; 2017 Aug; 71():16-25. PubMed ID: 28688685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma Patients: Meta-Analysis.
    Berele BA; Cai Y; Yang G
    Technol Cancer Res Treat; 2021; 20():15330338211034265. PubMed ID: 34323154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of the NKG2D ligand ULBP4 may be an indicator of poor prognosis in patients with nasopharyngeal carcinoma.
    Xu Y; Zhou L; Zong J; Ye Y; Chen G; Chen Y; Liao X; Guo Q; Qiu S; Lin S; Chen H; Pan J
    Oncotarget; 2017 Jun; 8(26):42007-42019. PubMed ID: 28159927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Infiltrating Lymphocytes as an Independent Prognostic Factor in Undifferentiated Nasopharyngeal Carcinoma.
    Febriani V; Indrawati I; Sumpono ASB; Ferronika P; Bawono RG; Dwianingsih EK
    Asian Pac J Cancer Prev; 2024 Jun; 25(6):1997-2002. PubMed ID: 38918661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma Cells.
    Makowska A; Lelabi N; Nothbaum C; Shen L; Busson P; Tran TTB; Eble M; Kontny U
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High miR-3650 expression in nasopharyngeal carcinoma and its clinical prognostic values.
    Ruan Q; Yang XZ; Zhu L; He QJ; Zhu SY; Wen YF; Ma L
    Pathol Res Pract; 2021 Aug; 224():153506. PubMed ID: 34091390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of CXCL1
    Wen YF; Huang WJ; Chen XL; Cai HT; Zhang YB; Song XL; Xie CB; Peng HH; Yu HW; Chen CC; Wei LQ; Zhou TC; Cai S; Wang F; Lin XD
    Oral Oncol; 2024 Oct; 157():106963. PubMed ID: 39032343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment.
    Ono T; Azuma K; Kawahara A; Sasada T; Matsuo N; Kakuma T; Kamimura H; Maeda R; Hattori C; On K; Nagata K; Sato F; Chitose SI; Shin B; Aso T; Akiba J; Umeno H
    Head Neck; 2018 Sep; 40(9):2007-2019. PubMed ID: 29756253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma.
    Tang Y; He Y; Shi L; Yang L; Wang J; Lian Y; Fan C; Zhang P; Guo C; Zhang S; Gong Z; Li X; Xiong F; Li X; Li Y; Li G; Xiong W; Zeng Z
    Oncotarget; 2017 Jun; 8(24):39001-39011. PubMed ID: 28380458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Wang YQ; Chen YP; Zhang Y; Jiang W; Liu N; Yun JP; Sun Y; He QM; Tang XR; Wen X; Yang XJ; Zhang PP; Zhang J; Lei Y; Li YQ; Ma J
    Int J Cancer; 2018 Jun; 142(12):2558-2566. PubMed ID: 29377121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
    Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
    Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.